Opendata, web and dolomites


INSIGHT FOR EYESIGHT – Novel mRNA medicines for eye disease

Total Cost €


EC-Contrib. €






Project "INSIGHT EU" data sheet

The following table provides information about the project.


Organization address
address: HERTOGPLEIN 24
postcode: 6511 SK
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Total cost 75˙937 €
 EC max contribution 75˙937 € (100%)
 Programme 1. H2020-EU. (Enhancing the innovation capacity of SMEs)
 Code Call H2020-INNOSUP-2019-02
 Funding Scheme CSA
 Starting year 2019
 Duration (year-month-day) from 2019-12-31   to  2020-12-30


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    MERCURNA BV NL (NIJMEGEN) coordinator 75˙937.00


 Project objective

Proper eyesight is essential for nearly all aspects of our life. Yet, over 4 million people suffer from reduced eyesight or blindness worldwide each year (30 million blind or partially sighted in EU, 1 in 3 senior (65) EU citizens faces sight loss). Common reasons include glaucoma, cataract, macular degeneration, diabetic retinopathy, corneal injury and inflammation, as well as complications of surgery of the eye and physical injury. Despite continuous improvements in treatment of various underlying causes, much is still to be gained in the promotion of healing of damaged eye tissue. While the patient suffers pain, loss of quality of life and participation in society, socio-economic costs include increased reliance on care-takers, increased healthcare cost and burden. Overall, the societal cost of eye disease is estimated to around 200 €Bn for the developed world. We envision the development of novel drug candidates, based on Mercurna’s proprietary messenger RNA (mRNA)-delivery platform, for greatly improved treatment of eye disease. A particularly interesting opportunity to explore in this project, is the use of mRNA to accelerate healing of the eye, a strategy that is applicable to multiple causes of eye disease. For this project, we aim to hire a researcher with a skillset and knowledge in the field of ophthalmology, who can critically strengthen Mercurna’s Innovation potential in this area.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "INSIGHT EU" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "INSIGHT EU" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.

EST-KAM20-21 (2020)

Estonian Key Account Management Services 2020-2021

Read More  

IMCESA-2021 (2020)

Innovation Management Capacity Enhancement of SMEs in Saxony-Anhalt for the period 2020-21

Read More  

DestinationUX (2019)

Improve SMEs experience from Innovation Support Programmes

Read More